Kyverna Therapeutics, Inc.KYTXNASDAQ
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank0
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Latest
-128.51%
↓ 104% vs avg
Percentile
P0
Near historical low
Streak
3 yr
Consecutive declineDecelerating
Average
-63.11%
Historical baseline
PeriodValue
2024-128.51%
2023-112.38%
2022-11.53%
20210.00%